tiprankstipranks
Trending News
More News >
Viemed Healthcare US (VMD)
:VMD
US Market
Advertisement

Viemed Healthcare (VMD) Earnings Dates, Call Summary & Reports

Compare
164 Followers

Earnings Data

Report Date
Mar 10, 2026
TBA (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.13
Last Year’s EPS
0.1
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted Viemed's strong revenue growth, successful integration of acquisitions, and expansion in sleep and maternal health segments. However, there were some concerns about gross margin pressures and narrowed revenue guidance. Overall, the positive developments in growth and expansion outweigh the negative aspects.
Company Guidance
During the Viemed Healthcare Third Quarter 2025 earnings call, the company provided detailed guidance reflecting their strong performance and strategic initiatives. The quarter saw record revenue of $71.9 million, a 24% year-over-year increase and 14% sequential growth, driven by both organic growth and the acquisition of Lehan's Medical Equipment. Viemed's ventilation business continued to grow with double-digit year-over-year revenue growth, though it now represents less than half of the company's net revenue, indicating a successful diversification strategy. Sleep services experienced significant expansion with new patient starts up 96% year-over-year, and their resupply population growing by 51% year-over-year and 33% sequentially. Adjusted EBITDA for the quarter was $16.1 million, a 16% increase from the previous year, with a margin of 22.4%. The company also highlighted the integration of Lehan's Medical Equipment, which contributed to their expansion into maternal health services and the national rollout of new offerings anticipated to boost growth in 2026. Viemed maintained a strong financial position with $11.1 million in cash and a focus on strategic capital allocation, including completing a share repurchase program. Looking ahead, Viemed updated its full-year outlook, forecasting net revenue between $271 million and $273 million and adjusted EBITDA between $60 million and $62 million, reflecting their strategic focus on high-margin areas and operational efficiencies.
Record Revenue Growth
Viemed reported record revenue of $71.9 million for Q3 2025, representing a 24% year-over-year growth and 14% sequential growth.
Significant Sleep Segment Expansion
New sleep patient starts grew 96% year-over-year, with the resupply population increasing 51% year-over-year and 33% sequentially.
Successful Integration of Lehan's Medical Equipment
The acquisition of Lehan's Medical Equipment resulted in immediate accretive growth, contributing 6% to the company's revenue.
Expansion in Maternal Health
Viemed successfully integrated maternal health products from Lehan's, poised to be a significant growth driver in 2026.
Strong Free Cash Flow Generation
Trailing 12-month free cash flow reached $23.3 million, showing significant improvement and providing flexibility for investments.

Viemed Healthcare (VMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

VMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 10, 2026
2025 (Q4)
0.13 / -
0.1
Nov 05, 2025
2025 (Q3)
0.09 / 0.09
0.1-10.00% (-0.01)
Aug 06, 2025
2025 (Q2)
0.09 / 0.08
0.04100.00% (+0.04)
May 07, 2025
2025 (Q1)
0.06 / 0.06
0.0450.00% (+0.02)
Mar 10, 2025
2024 (Q4)
0.10 / 0.10
0.0911.11% (+0.01)
Nov 06, 2024
2024 (Q3)
0.07 / 0.10
0.0742.86% (+0.03)
Aug 07, 2024
2024 (Q2)
0.07 / 0.04
0.06-33.33% (-0.02)
May 06, 2024
2024 (Q1)
0.07 / 0.04
0.040.00% (0.00)
Mar 06, 2024
2023 (Q4)
0.10 / 0.09
0.0650.00% (+0.03)
Nov 01, 2023
2023 (Q3)
0.10 / 0.07
0.03133.33% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

VMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$6.43$6.26-2.64%
Aug 06, 2025
$6.45$6.96+7.91%
May 07, 2025
$7.27$6.42-11.69%
Mar 10, 2025
$7.40$7.80+5.41%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Viemed Healthcare US (VMD) report earnings?
Viemed Healthcare US (VMD) is schdueled to report earning on Mar 10, 2026, TBA (Confirmed).
    What is Viemed Healthcare US (VMD) earnings time?
    Viemed Healthcare US (VMD) earnings time is at Mar 10, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is VMD EPS forecast?
          VMD EPS forecast for the fiscal quarter 2025 (Q4) is 0.13.

            Viemed Healthcare (VMD) Earnings News

            Viemed Healthcare Stock Finishes 14.2% Lower on Earnings Miss
            Premium
            Market News
            Viemed Healthcare Stock Finishes 14.2% Lower on Earnings Miss
            3y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis